Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Nutex Health Inc. following a class action complaint filed on August 22, 2025, concerning alleged breaches of fiduciary duties by the company's board of directors during the class period from August 8, 2024, to August 14, 2025 [1][2]. Summary by Sections Allegations - The complaint alleges that Nutex's management made materially false and misleading statements regarding the company's business and operations, including: - Engaging in a scheme to defraud insurance companies through HaloMD, leading to unsustainable revenues [2]. - Overstating the remediation of material weaknesses in internal controls over financial reporting [2]. - Improperly accounting for stock-based compensation obligations as equity instead of liabilities [2]. - Increased risk of failing to timely file financial reports with the SEC due to these issues [2]. - Overall, the company's business and financial prospects were overstated, making public statements materially false and misleading [2]. Next Steps for Investors - Long-term stockholders of Nutex are encouraged to contact Bragar Eagel & Squire for more information regarding their rights and potential claims related to the allegations [3]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various complex litigations across state and federal courts [4].

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming October 21, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Nutex Health Inc. ("Nutex†or the "Company†) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the "Class Period†). IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUTEX HEALTH INC. (NUTX), CLICK HERE TO PARTICIPATE IN THE SECURIT. ...

NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHA ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 14, 2025and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar ...

Accessibility StatementSkip Navigation NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our te ...

Accessibility StatementSkip Navigation NUTX Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with ...

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. on behalf of shareholders who purchased securities between August 8, 2024, and August 14, 2025, indicating potential legal challenges for the company [1]. Company Summary - Nutex Health Inc. is described as a "physician-led, healthcare services and operations company," highlighting its focus on healthcare delivery and management [1]. Legal Investigation - The Rosen Law Firm is investigating allegations related to the class action, which may impact the company's reputation and financial standing [1].

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/nutex-h ...

SAN FRANCISCO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with third-party billing firm HaloMD to submit ineligible insurance claims, misleading shareholders and ...

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. for allegedly making materially false and misleading statements regarding its business operations and financial prospects during the specified Class Period from August 8, 2024, to August 14, 2025 [8]. Allegation Details - The lawsuit claims that Nutex engaged in a scheme to defraud insurance companies through HaloMD, leading to unsustainable revenue [3]. - It is alleged that Nutex overstated its ability to remediate material weaknesses in its internal controls over financial reporting [3]. - The company reportedly misclassified stock-based compensation obligations, increasing the risk of failing to file timely financial reports with the SEC [3]. - Overall, the public statements made by Nutex were deemed materially false and misleading throughout the relevant period [3]. Next Steps - Investors who purchased Nutex shares and suffered losses are encouraged to contact the law firm for more information regarding their rights and potential claims [4]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 21, 2025 [8]. About the Law Firm - Bragar Eagel & Squire, P.C. is a recognized law firm specializing in representing individual and institutional investors in complex litigation [5].